ICD-11 MMS

02 Neoplasms

Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues  (2B50-2E2Z)

Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues  (2B50-2D3Z)

Malignant neoplasms of male genital organs  (2C80-2C8Z)

Malignant neoplasms of prostate

International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01


Prostate cancer contributes significantly to the overall cancer burden, being the most frequent malignant neoplasia in men. The number of cases has continuously increased over the past decades, partly due to the higher life expectancy. An additional factor is the Western lifestyle, characterised by a highly caloric diet and lack of physical exercise. Epidemiological data indicates that black people are most susceptible, followed by white people, while Asian people have the lowest risk. The extent to which prostate cancer mortality can be reduced by PSA screening is currently being evaluated. Histopathological diagnosis and grading play a major role in the management of prostate cancer.

exclusions

sections/codes in this section (2C82-2C82)

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.